...
首页> 外文期刊>Clinical nuclear medicine >68Ga-DOTA-Exendin PET-MRI Fusion Imaging in a Case of Insulinoma
【24h】

68Ga-DOTA-Exendin PET-MRI Fusion Imaging in a Case of Insulinoma

机译:68Ga-dota-Exendin PET-MRI融合成像在胰岛素瘤的情况下

获取原文
获取原文并翻译 | 示例
           

摘要

Persistent hyperinsulinemic hypoglycemia in adults is most commonly caused by insulinomas, which pose a diagnostic challenge to physicians, surgeons, and radiologists and require multimodality imaging for precise localization and staging. PET tracers such as F-18-FDOPA and glucagon-like peptide 1 receptor analogs have been used for imaging insulinomas. Glucagon-like peptide 1 receptor analogs have recently shown promising results in preoperative localization of these tumors, as all insulinomas express glucagon-like peptide 1 receptors. Ga-68-DOTA-Exendin PET and MRI done in the present case helped in precise localization and management of the culprit lesion, whereas contrast-enhanced CT and F-18-FDOPA PET failed to do so.
机译:持续的高胰岛素血症成人中的低血糖性低血糖最常见于胰岛素瘤引起的,这对医生,外科医生和放射科医师构成了诊断挑战,并且需要多模态成像以获得精确定位和分期。 宠物示踪剂如F-18-FDOPA和胰高血糖素样肽1受体类似物已用于成像胰岛素瘤。 胰高血糖素样肽1受体类似物最近显示出有前途的导致这些肿瘤的术前定位,作为所有胰岛素表达胰高血糖素样肽1受体。 GA-68-DOTA-EXENDIN PET和MRI在本案例中完成了精确的本地化和罪魁祸首的管理,而对比度增强的CT和F-18-FDOPA PET未能这样做。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号